ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,247.79
-0.41%
Dow Jones
39,112.16
-0.76%
Gold vs US Dollar
2,321.185
-0.42%
Brent Oil
84.185
-1.27%
Bitcoin
61,719.23
2.42%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Newellis Inc (NUWE)

  7. Newellis Inc (NUWE) News

Newellis (NUWE)

Newellis Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NUWE
DateTimeSourceHeadlineSymbolCompany
25/06/202414:00GlobeNewswire Inc.Nuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™NASDAQ:NUWENewellis Inc
10/06/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
06/06/202414:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
06/06/202414:00GlobeNewswire Inc.Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot PhaseNASDAQ:NUWENewellis Inc
29/05/202416:54Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:NUWENewellis Inc
17/05/202422:22Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:NUWENewellis Inc
17/05/202422:20Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:NUWENewellis Inc
14/05/202414:00GlobeNewswire Inc.Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in FloridaNASDAQ:NUWENewellis Inc
09/05/202414:00GlobeNewswire Inc.Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration TherapyNASDAQ:NUWENewellis Inc
08/05/202422:28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NUWENewellis Inc
08/05/202422:26Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:NUWENewellis Inc
07/05/202413:00GlobeNewswire Inc.Nuwellis, Inc. Announces First Quarter 2024 Financial ResultsNASDAQ:NUWENewellis Inc
02/05/202414:00GlobeNewswire Inc.Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT TechnologyNASDAQ:NUWENewellis Inc
30/04/202423:09GlobeNewswire Inc.Nuwellis Announces Closing of $2.7 Million Public OfferingNASDAQ:NUWENewellis Inc
30/04/202421:41GlobeNewswire Inc.Nuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:NUWENewellis Inc
26/04/202414:17GlobeNewswire Inc.Nuwellis Announces Pricing of $2.7 Million Public OfferingNASDAQ:NUWENewellis Inc
09/04/202414:00GlobeNewswire Inc.Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford HealthNASDAQ:NUWENewellis Inc
11/03/202421:08Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NUWENewellis Inc
07/03/202414:08GlobeNewswire Inc.Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics ConferenceNASDAQ:NUWENewellis Inc
06/03/202417:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
05/03/202413:00GlobeNewswire Inc.Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:NUWENewellis Inc
05/03/202411:05IH Market NewsU.S. Futures Dip, Crude Oil FluctuatesNASDAQ:NUWENewellis Inc
27/02/202414:00GlobeNewswire Inc.Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024NASDAQ:NUWENewellis Inc
22/02/202412:58GlobeNewswire Inc.Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™NASDAQ:NUWENewellis Inc
20/02/202422:06GlobeNewswire Inc.Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:NUWENewellis Inc
20/02/202413:42GlobeNewswire Inc.Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Heart Failure Therapeutics ConferenceNASDAQ:NUWENewellis Inc
08/02/202422:19Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:NUWENewellis Inc
06/02/202414:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
06/02/202414:00GlobeNewswire Inc.New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid OverloadNASDAQ:NUWENewellis Inc
09/01/202422:30Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:NUWENewellis Inc
 Showing the most relevant articles for your search:NASDAQ:NUWE

Your Recent History

USOTC
EVVL
Evil Empire Designs (CE)
LSE
40BR
Arab Rep.egp 26
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved